Should You Buy Eli Lilly Stock Before June 22?
(NYSE: LLY) stock hasn't been doing too well this year, but that could change later this month. A couple of key events are on the horizon this month during which the company will release new data from studies relating to multiple GLP-1 drugs. They can give investors insights into how well the drugs are doing, and whether approvals for new drugs and indications could be forthcoming in the near future.
If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should you invest in this top healthcare company before June 22?
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Eli Lilly to present data on multiple drugs later this month
The American Diabetes Association (ADA) is hosting its 85th Scientific Sessions event in Chicago later this month, from June 20 to 23. Eli Lilly will report on data from studies related to multiple GLP-1 drugs, including tirzepatide (already approved for weight loss and diabetes under the Zepbound and Mounjaro brands), orforglipron (its oral weight-loss medication), and retatrutide -- one of the most promising GLP-1 treatments in the company's pipeline. On June 22, Eli Lilly will also be hosting an investor event which will go over key presentations from the ADA Scientific Sessions.
For investors, there will be a lot of important data to unpack from all this. Encouraging data from key drugs could help lift shares of the company, as it may give investors reason to be bullish on further drug approvals, which would lead to stronger growth prospects for Eli Lilly and greater upside for the stock.
The stock has struggled this year
As of the end of last week, shares of Eli Lilly were flat since the start of 2025. There hasn't been a catalyst to send the stock soaring. While it has reached highs of more than $900 this year, fears of healthcare reform and a slowdown in the economy appear to be weighing on its valuation.
Plus, with the stock trading at more than 60 times its trailing earnings, there can't be any hiccups along the way for Eli Lilly. At that high of a multiple, investors are going to be demanding near perfection from the business.
However, Eli Lilly has been performing well. In the trailing 12 months, it has generated revenue of more than $49 billion, and its profits on that have totaled $11.1 billion. Just a few years ago, in 2022, this was a business that was only bringing in less than $29 billion in revenue. Its profit that year was much more modest at $6.2 billion. The growth in its new GLP-1 drugs has transformed the business in a strong, positive way. And that's why strong and impressive data from the upcoming ADA event could be what gets the stock rallying again.
Should you buy Eli Lilly before June 22?
Eli Lilly is a strong and robust business, with some promising growth prospects on the horizon. This is a stock I firmly believe can reach a $1 trillion valuation within the next few years, given just how much growth it may achieve. And if that's the case, its upside could be more than 45% from where it is today.
While its year-to-date returns look unimpressive, this is a stock that has a lot more room to rise higher. Although Eli Lilly may not be the cheapest stock to own, a premium looks justifiable when factoring in the company's recent results and future growth opportunities. Buying it before the upcoming ADA event, which may light a fire under its valuation, could be a great move for investors in the long run.
Should you invest $1,000 in Eli Lilly right now?
Before you buy stock in Eli Lilly, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,341!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $874,192!*
Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 9, 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
23 minutes ago
- Globe and Mail
Palantir-Backed (PLTR) Voyager's IPO Tests Market Demand for Space Stocks
Voyager Technologies is holding its initial public offering (IPO) on June 11 in what Wall Street says is a test of market demand for high-flying space stocks. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Voyager's shares will begin trading on the New York Stock Exchange under the ticker symbol 'VOYG.' The defense and space technology company priced its shares at $31, above the original range of $26 to $29. Voyager counts Palantir Technologies (PLTR) and Lockheed Martin (LMT) among its biggest backers, and the Air Force and NASA as customers. Management at Voyager raised the size of the stock sale from 11 million shares initially to 12.35 million. At the $31 IPO price, Voyager has a starting market capitalization of $1.90 billion. The company raised $382.8 million from its IPO. The listing of VOYG stock comes a week after the blockbuster IPO of stablecoin issuer Circle (CRCL) and ahead of online banking company Chime Financial on June 12. Strong Finances Voyager makes its market debut with some strong finances underpinning its stock. The Colorado-based company has a $217.5 million contract with NASA to help design Starlab, a commercial space station that will replace the International Space Station when it is decommissioned in 2030. NASA is Voyager's largest customer, accounting for more than a quarter of the company's $144.2 million in 2024 sales. Voyager's revenue grew 6% last year and another 14% in this year's first quarter. However, like many start-up companies, Voyager is not yet profitable, reporting a -$65.6 million net loss in 2024. Heading into the IPO, analysts said that Voyager is well-positioned to take part in national security contracts such as U.S. President Donald Trump's plans for a Golden Dome missile-defense shield. Is VOYG Stock a Buy? It's too early for there to be any Wall Street ratings or price targets on Voyager stock. So instead, we'll look at Palantir's stock. The stock of Palantir Technologies has a consensus Hold rating among 18 Wall Street analysts. That rating is based on three Buy, 11 Hold, and four Sell recommendations issued in the last three months. The average PLTR price target of $101.06 implies 26.18% downside from current levels.
Globe and Mail
24 minutes ago
- Globe and Mail
Why Boeing Stock Is Under Pressure Today
A Boeing (NYSE: BA) 787 Dreamliner carrying 242 people crashed in India, reportedly leaving few, if any, survivors. Though the human tragedy is the primary focus, the incident also raises fresh concerns about safety. Shares of Boeing traded down 5% as of 10 a.m. ET, and shares of engine maker GE Aerospace (NYSE: GE) were down 2%. Fresh uncertainty clouds the investment picture Air India flight 171 took off from Ahmedabad en route to London, but crashed shortly after takeoff, according to reports. It is the first fatal incident involving a Dreamliner, which has been in service since October 2011. It will take months, if not years, to determine the cause of the incident, and there are a wide range of potential factors, including weather, human error, and maintenance that will be considered on top of manufacturing issues. But for Boeing, which is in the process of rehabilitating its reputation after a pair of fatal accidents involving its 737 MAX aircraft, the incident creates fresh investor uncertainty just as the company appeared to be regaining its footing. No easy answers from here The best advice for investors is to do nothing at all. Expect there to be few definitive conclusions about what happened for some time, and in many cases, incidents like this are the result of a cascade of different factors. Even before today's incident, Boeing investors were in for a long journey. The aerospace company expanded its total debt by more than 400% during the pandemic and still faces government production restrictions on the 737 MAX that limits its cash flow and its ability to pay down that balance. Boeing has refreshed its management and is making strides to meet government requirements to expand production. We're still far from drawing any conclusions about whether the Air India incident will impact the company's course. Should you invest $1,000 in Boeing right now? Before you buy stock in Boeing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Boeing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,871!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $875,479!* Now, it's worth noting Stock Advisor 's total average return is998% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
National Post
34 minutes ago
- National Post
Divorce battle between Ryan Lochte and Playboy model gets heated with demand
In her divorce battle against U.S. Olympic great Ryan Lochte, Kayla Rae Reid reportedly is aiming to put the swimmer out to sea. Article content According to court documents obtained by Us Magazine, the former Playboy model has demanded exclusive use of the marital home that she and the 12-time Olympic medallist own in Terrace, Fla. Article content Article content '(Kayla) needs the exclusive use of this home and the contents thereof both now and in the future for herself and the minor children,' the filing reads. Article content The doc indicated that Lochte has been staying in a separate home — valued at US$440,000 — since the couple split in March. Article content Reid also claims in her petition that, during their marriage, the former swimmer took several joint assets and income and used them to purchase other assets — some of which are in his name. Article content '(Those) assets are presently being held by (Ryan) in trust for and for all the benefit of (Kayla), and the court should award to (Kayla) her full interest in said assets,' her filing continued. Article content Article content Reid also is asking for a piece of two business — Lochte Enterprises and Legendaryswimming – which she invested in with her estranged husband during their marriage. Article content '(Kayla) makes a claim for equitable distribution of the corporate defendant because she has been of great assistance of (Ryan), only in the marital business but also in terms of providing a home environment which supported (Ryan's) needs in every respect.' Article content While Reid filed for the divorce on March 26, the couple only announced the split last week on their social media accounts. Article content Article content Reid, a former Playboy model, described ending the marriage as 'one of the most painful' decisions of her life. Article content View this post on Instagram A post shared by Kayla Lochte | Gainesville, FL Realtor 🏡 (@kaylaraereid)
